Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer

AIM: Neoadjuvant chemotherapy (NAC) is promising to improve the survival of resectable gastric cancer. However, suitable regimen and treatment duration for NAC have not yet been established. METHODS: We conducted a randomized phase II trial to compare two and four courses of neoadjuvant S‐1/cisplati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Tsutomu, Yoshikawa, Takaki, Sakamaki, Kentaro, Nishikawa, Kazuhiro, Fujitani, Kazumasa, Tanabe, Kazuaki, Misawa, Kazunari, Matsui, Takanori, Miki, Akira, Nemoto, Hiroshi, Fukunaga, Tetsu, Kimura, Yutaka, Hihara, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511564/
https://www.ncbi.nlm.nih.gov/pubmed/33005849
http://dx.doi.org/10.1002/ags3.12352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511564/
https://www.ncbi.nlm.nih.gov/pubmed/33005849
http://dx.doi.org/10.1002/ags3.12352

Ejemplares similares